Tasrif Pharmaceutical

Press Release

July 29, 2026

Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)

https://www.globenewswire.com/news-release/2026/07/29/3335006/0/en/tasrif-pharmaceutical-announces-grant-of-second-u-s-patent-for-humanized-monoclonal-antibodies-against-the-poliovirus-receptor-cd155.html

August 30, 2021

Tasrif Pharmaceutical Announces Grant of US Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor.

https://www.einpresswire.com/article/549915558/tasrif-pharmaceutical-announces-grant-of-us-patent-for-humanized-monoclonal-antibodies-against-the-poliovirus-receptor

August 25, 2021

Tasrif Pharmaceutical Announces Grant of US Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor.

https://www.globenewswire.com/news-release/2021/08/25/2286549/0/en/Tasrif-Pharmaceutical-Announces-Grant-of-U-S-Patent-for-Humanized-Monoclonal-Antibodies-against-the-Poliovirus-Receptor.html